Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012... Show more
In recent trading sessions, Mondelez International (MDLZ) stock has hovered in a tight range within the mid-$50s, balancing year-to-date gains against longer-term pressures from elevated commodity costs. The shares have underperformed over the past year amid snack sector headwinds but shown resilience in the latest market cycle. Investor focus remains on profitability amid input cost volatility, with moderate volume underscoring a wait-and-see posture ahead of key catalysts. Broader consumer staples sentiment, influenced by shifting demand patterns, has kept price action contained, positioning MDLZ for potential volatility tied to upcoming disclosures.
Tickeron's Trending AI Robots page curates a select group of top-performing AI trading bots from its extensive library of hundreds of bots that trade thousands of different tickers across stocks, ETFs, and crypto. Only the best and most suitable for prevailing market conditions earn a spot in this dynamic section, which currently showcases over 25 robots selected from a total of 351. These bots employ diverse trading styles—from short-term scalping on 5-minute charts to longer-term strategies—using technical or fundamental analysis tailored to low, medium, or high volatility environments. AI Trading Signal Agents provide real-time alerts without minimum balances, while Virtual and Brokerage Agents incorporate advanced risk management. This variety empowers traders to match bots to their risk tolerance and timeframe, potentially enhancing performance in uncertain markets like today's. Explore the page to discover bots aligned with your strategy.
Mondelez International (MDLZ) stock has experienced contained volatility in the past 30 days, largely shaped by anticipation surrounding its Q1 2026 earnings release scheduled for April 28. Analysts project revenue of approximately $9.77 billion, reflecting modest growth, but EPS of $0.61, a decline from prior-year levels due to lingering commodity pressures. This outlook follows Q4 2025 results where profits fell amid surging cocoa costs, a key input for Mondelez's chocolate portfolio including brands like Cadbury and Milka.
Commodity dynamics remained a focal point. On April 19, reports highlighted Mondelez's pivot toward lab-grown cocoa to mitigate supply risks and $12,000-per-ton price spikes earlier in the cycle, signaling proactive margin defense. Cocoa prices subsequently plummeted by April 14, offering potential relief but underscoring ongoing volatility that has pressured consumer packaged goods peers. These developments contributed to a cautious trading range, with shares dipping slightly as investors weighed cost pass-through capabilities against softening volumes.
Analyst sentiment showed nuance. RBC Capital noted near-term demand headwinds on April 22, tempering enthusiasm, while BTIG initiated coverage with a "Buy" rating and $70 target on April 14, citing structural strengths. Goldman Sachs reiterated "Buy" on April 21, and Bank of America raised its target to $65 from $62 on April 10, balancing cocoa risks with emerging market potential. Earlier March adjustments, like TD Cowen's target cut to $62 and Rothschild Redburn's downgrade citing volume concerns, had initially weighed on sentiment but stabilized as positive notes emerged.
Operational highlights included a Nilla Wafers Star Wars collaboration launched recently, aiming to boost category volumes, alongside upcoming ESG shareholder votes that could influence governance perceptions. Macro factors, such as consumer spending shifts and ultraprocessed food scrutiny, added backdrop pressure but did not trigger sharp moves. Overall, price stability reflects balanced expectations for earnings clarity on cost hedging and organic growth.
As Mondelez International progresses through 2026, investors should track cocoa price trajectories and hedging efficacy, given their outsized impact on chocolate margins. Company guidance points to flat-to-2% organic net revenue (ONR) growth and flat-to-5% adjusted EPS expansion, predicated on volume recovery and pricing discipline. Opportunities lie in emerging markets, where snacking trends favor power brands like Oreo, and innovations such as lab-grown cocoa could fortify supply chains against climate risks.
Risks include persistent inflation eroding consumer demand, particularly in volume-sensitive categories, and competitive intensification from private labels. Regulatory scrutiny on sustainable sourcing and nutrition may elevate compliance costs, while macroeconomic slowdowns could hinder premiumization efforts. Strategic M&A (mergers and acquisitions) in health-focused snacks and digital commerce expansion represent potential catalysts. Monitoring quarterly volume/mix dynamics, cost inflation pass-through, and dividend sustainability will be crucial for assessing long-term positioning in a dynamic CPG (consumer packaged goods) landscape.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MDLZ advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 55 cases where MDLZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
MDLZ moved above its 50-day moving average on June 23, 2026 date and that indicates a change from a downward trend to an upward trend.
The Aroon Indicator entered an Uptrend today. In of 220 cases where MDLZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for MDLZ moved out of overbought territory on June 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on June 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MDLZ as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for MDLZ turned negative on June 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDLZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MDLZ broke above its upper Bollinger Band on June 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.966) is normal, around the industry mean (3.216). P/E Ratio (29.460) is within average values for comparable stocks, (23.286). Projected Growth (PEG Ratio) (0.977) is also within normal values, averaging (0.979). Dividend Yield (0.033) settles around the average of (0.025) among similar stocks. P/S Ratio (1.958) is also within normal values, averaging (1.928).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MDLZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDLZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of packaged food products
Industry FoodSpecialtyCandy